Início › Câncer de Ovário › Wisconsin › Madison
Ensaios clínicos de Câncer de Ovário em Madison, WI
13 estudos para Câncer de Ovário estão buscando participantes em locais em Madison e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RecrutandoFase 2/3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecrutandoFase 2
- UW Health Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecrutandoFase 2
- Research Site, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- University of Wisconsin - Carbone Cancer Center, Madison
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
RecrutandoFase 2
- University of Wisconsin, Madison
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
RecrutandoEstudo observacional
- UW Carbone Cancer Center, Madison
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
RecrutandoFase 2
- University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecrutandoFase 1/2
- University of Wisconsin, Madison
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
RecrutandoFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Madison
- Câncer de Próstata29 estudos
- Câncer Colorretal23 estudos
- Câncer de Mama22 estudos
- Câncer Metastático21 estudos
- Leucemia Mieloide Aguda16 estudos
- Câncer de Pulmão de Não Pequenas Células16 estudos
- Melanoma15 estudos
- Câncer (todos os tipos)14 estudos
- Câncer de Estômago11 estudos
- Câncer de Pâncreas10 estudos
- Câncer de Pulmão10 estudos
- Mieloma Múltiplo9 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.